Medexus Pharmaceuticals Inc banner

Medexus Pharmaceuticals Inc
TSX:MDP

Watchlist Manager
Medexus Pharmaceuticals Inc Logo
Medexus Pharmaceuticals Inc
TSX:MDP
Watchlist
Price: 3.12 CAD 2.63% Market Closed
Market Cap: CA$101.2m

Profitability Summary

Medexus Pharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Medexus Pharmaceuticals Inc

Margins Comparison
Medexus Pharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CA
Medexus Pharmaceuticals Inc
TSX:MDP
100.8m CAD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
869B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
588.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
233B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.7B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
231.9B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
159.7B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.3B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Medexus Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
Medexus Pharmaceuticals Inc
TSX:MDP
100.8m CAD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
869B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
588.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
233B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
231.9B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
159.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.3B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Medexus Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett